These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18519084)

  • 1. Dysregulation of renal aquaporins and epithelial sodium channel in lithium-induced nephrogenic diabetes insipidus.
    Nielsen J; Kwon TH; Christensen BM; Frøkiaer J; Nielsen S
    Semin Nephrol; 2008 May; 28(3):227-44. PubMed ID: 18519084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus.
    van Os CH; Deen PM
    Proc Assoc Am Physicians; 1998; 110(5):395-400. PubMed ID: 9756089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polyuria and polydipsia due to renal diabetes insipidus during the use of lithium].
    Huyse FJ
    Ned Tijdschr Geneeskd; 2007 Jan; 151(2):152-3. PubMed ID: 17315495
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of prolonged lithium therapy-induced nephrogenic diabetes insipidus.
    Behl T; Kotwani A; Kaur I; Goel H
    Eur J Pharmacol; 2015 May; 755():27-33. PubMed ID: 25746463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications during lithium maintenance therapy].
    Di Paolo A
    Rev Med Brux; 2005; 26(3):173-7. PubMed ID: 16038143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lithium and its relation with the epithelial sodium channel and aquaporin-2].
    Galizia L; Marino GI; Kotsias BA
    Medicina (B Aires); 2012; 72(2):171-5. PubMed ID: 22522861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.
    Kim GH; Lee JW; Oh YK; Chang HR; Joo KW; Na KY; Earm JH; Knepper MA; Han JS
    J Am Soc Nephrol; 2004 Nov; 15(11):2836-43. PubMed ID: 15504936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Water, lithium and sodium: watch out for dangerous injuries].
    Fayolle M; Souweine JS; Mathieu O; Bargnoux AS; Cristol JP; Badiou S
    Ann Biol Clin (Paris); 2020 Aug; 78(4):449-453. PubMed ID: 32618565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium: a review of its metabolic adverse effects.
    Livingstone C; Rampes H
    J Psychopharmacol; 2006 May; 20(3):347-55. PubMed ID: 16174674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium-induced NDI in rats is associated with loss of alpha-ENaC regulation by aldosterone in CCD.
    Nielsen J; Kwon TH; Frøkiaer J; Knepper MA; Nielsen S
    Am J Physiol Renal Physiol; 2006 May; 290(5):F1222-33. PubMed ID: 16332930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of nephrogenic diabetes insipidus.
    Nguyen MK; Nielsen S; Kurtz I
    Clin Exp Nephrol; 2003 Mar; 7(1):9-17. PubMed ID: 14586738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lithium and chronic kidney disease: a pathology which remains relevant].
    Félix P; Stoermann-Chopard C; Martin PY
    Rev Med Suisse; 2010 Mar; 6(238):448-52. PubMed ID: 20344995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent nephrogenic diabetes insipidus following lithium therapy.
    Thompson CJ; France AJ; Baylis PH
    Scott Med J; 1997 Feb; 42(1):16-7. PubMed ID: 9226773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal side effects of long-term lithium therapy].
    Ibbeken C; Becker JU; Baumgärtel MW
    Dtsch Med Wochenschr; 2012 Jan; 137(4):143-8. PubMed ID: 22259170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings.
    Trepiccione F; Christensen BM
    J Nephrol; 2010; 23 Suppl 16():S43-8. PubMed ID: 21170888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
    de Groot T; Sinke AP; Kortenoeven ML; Alsady M; Baumgarten R; Devuyst O; Loffing J; Wetzels JF; Deen PM
    J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cellular plasticity in the collecting duct during recovery from lithium-induced nephrogenic diabetes insipidus.
    Trepiccione F; Capasso G; Nielsen S; Christensen BM
    Am J Physiol Renal Physiol; 2013 Sep; 305(6):F919-29. PubMed ID: 23825070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polyuria and polydipsia due to renal diabetes insipidus during the use of lithium].
    van Gerven HA; Boer WH
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1705-9. PubMed ID: 16924939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium intoxication-induced acute parkinsonism complicated with hyperparathyroidism and nephrogenic diabetes insipidus: report of a case.
    Shen HC; Li JY; Lo YK
    Acta Neurol Taiwan; 2007 Dec; 16(4):231-3. PubMed ID: 18220017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.